Occult axillary node metastases in breast cancer: their detection and prognostic significance.

Occult axillary node metastases in breast cancer: their detection and prognostic significance.
复制标题

乳腺癌中的神秘腋窝淋巴结转移:它们的检测和预后意义。

DOI:
10.1038/bjc.1996.16
复制
发表时间:
1996-01
影响因子:
8.8
通讯作者:
Wright, R G
Wright, R G
中科院分区:
医学1区
文献类型:
--
作者:
McGuckin, M A;Cummings, M C;Walsh, M D;Hohn, B G;Bennett, I C;Wright, R G

文献摘要

被引文献

相似文献

虽然乳腺癌腋窝淋巴结转移的存在是一个关键的预后指标,并可能影响治疗决策,但使用标准组织病理学技术诊断为腋窝淋巴结阴性(ANN)的患者中,有相当大比例可能有隐匿性淋巴结转移(OM)。在208例ANN患者中,采用有限步切法(间隔4×100微米)和免疫组织化学染色(细胞角蛋白(MNF.116)和MUC1(BC2)抗体)相结合的方法检测OM。53例(25%)发现OMS,分步切片法和免疫组织化学检测均显著提高了OMS的检出率(P<0.05)。BC2法(25%)优于MNF.116法(18%)和苏木精伊红(8%)法。51例患者仅使用第一和最深层面的切片和BC2染色即可发现OMS。OMS在小叶(38%)比导管癌(25%)更常见,在50岁以下的女性(41%)比老年女性(19%)更常见。单变量总体和无病生存分析显示,OM的存在、大小和数量以及肿瘤大小(仅限于无病)以及组织学和核分级对预后有意义(P>0.05)。COX多因素比例风险回归分析显示,独立于其他预后因素,OMS的存在和增大与较差的无病生存率显著相关(P<0.05)。然而,隐匿性转移的存在与总存活率之间并没有显着的独立关联(P=0.11)。这些发现对于选择ANN患者进行辅助治疗具有重要的意义。
Although the presence of axillary node metastases in breast cancer is a key prognostic indicator and may influence treatment decisions, a significant proportion of patients diagnosed as axillary node negative (ANN) using standard histopathological techniques may have occult nodal metastases (OMs). A combination of limited step-sectioning (4 x 100 microns intervals) and immunohistochemical staining (with cytokeratin (MNF.116) and MUC1 (BC2) antibodies) was used to detect OM in a retrospective series of 208 ANN patients. OMs were found in 53 patients (25%), and both step-sectioning and immunohistochemical detection significantly improved detection (P < 0.05). Detection using BC2 (25%) was superior to MNF.116 (18%) and haematoxylin and eosin (H&E) (8%). OMs were found in 51 patients using only the first and deepest sectioning levels and BC2 staining. OMs were more frequently found in lobular (38%) than ductal carcinoma (25%), and more frequently in women less than 50 years (41%) than in older women (19%). Univariate overall and disease-free survival analyses showed that the presence, size and number of OM had prognostic significance as did tumour size (disease-free only) and histological and nuclear grade (P > 0.05). Cox multivariate proportional hazard regression analyses showed that the presence and increasing size of OMs were significantly associated with poorer disease-free survival, independently of other prognostic factors (P < 0.05). However there was not a significant independent association of the presence of occult metastases with overall survival (P = 0.11). These findings have important implications with regard to selection of ANN patients for adjuvant therapy.